These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 30601027)

  • 1. Systematic review of preclinical, clinical, and post-marketing evidence of bupropion misuse potential.
    Naglich AC; Brown ES; Adinoff B
    Am J Drug Alcohol Abuse; 2019; 45(4):341-354. PubMed ID: 30601027
    [No Abstract]   [Full Text] [Related]  

  • 2. Bupropion abuse resulting in hypomania in a geriatric amphetamine user: A case report.
    Rostas A; Wolf U
    Am J Addict; 2015 Dec; 24(8):765-6. PubMed ID: 26587916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute doses of d-amphetamine and bupropion increase cigarette smoking.
    Cousins MS; Stamat HM; de Wit H
    Psychopharmacology (Berl); 2001 Sep; 157(3):243-53. PubMed ID: 11605079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects.
    Costa R; Oliveira NG; Dinis-Oliveira RJ
    Drug Metab Rev; 2019 Aug; 51(3):293-313. PubMed ID: 31124380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of treating cathinone dependence and comorbid depression using bupropion.
    Lev-Ran S
    J Psychoactive Drugs; 2012; 44(5):434-6. PubMed ID: 23457895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
    Ng QX
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):112-116. PubMed ID: 27813651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004.
    Beyens MN; Guy C; Mounier G; Laporte S; Ollagnier M
    Drug Saf; 2008; 31(11):1017-26. PubMed ID: 18840021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion hydrochloride produces conditioned hyperactivity in rats.
    Wilkinson JL; Bevins RA
    Physiol Behav; 2007 Apr; 90(5):790-6. PubMed ID: 17300819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights.
    Paterson NE
    Eur J Pharmacol; 2009 Jan; 603(1-3):1-11. PubMed ID: 19101536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of bupropion on psychomotor performance.
    Paul MA; Gray G; Kenny G; Lange M
    Aviat Space Environ Med; 2002 Nov; 73(11):1094-9. PubMed ID: 12433233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational analysis and a crystal structure of bupropion, an antidepressant with dopamine reuptake blocking activity.
    Froimowitz M; George C
    J Chem Inf Comput Sci; 1998; 38(3):506-10. PubMed ID: 9611786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of In Vitro Stereoselective Metabolism of Bupropion in Human, Monkey, Rat, and Mouse Liver Microsomes.
    Bhattacharya C; Kirby D; Van Stipdonk M; Stratford RE
    Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):261-274. PubMed ID: 30298475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of bupropion for smoking cessation.
    Richmond R; Zwar N
    Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion diversion and misuse in the correctional facility.
    Hilliard WT; Barloon L; Farley P; Penn JV; Koranek A
    J Correct Health Care; 2013 Jul; 19(3):211-7. PubMed ID: 23788587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-generation antidepressants for preventing seasonal affective disorder in adults.
    Gartlehner G; Nussbaumer B; Gaynes BN; Forneris CA; Morgan LC; Kaminski-Hartenthaler A; Greenblatt A; Wipplinger J; Lux LJ; Sonis JH; Hofmann J; Van Noord MG; Winkler D
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011268. PubMed ID: 26558418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion for the treatment of nicotine withdrawal and craving.
    Mooney ME; Sofuoglu M
    Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.
    Dwoskin LP; Rauhut AS; King-Pospisil KA; Bardo MT
    CNS Drug Rev; 2006; 12(3-4):178-207. PubMed ID: 17227286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.
    Anderson LS; Bell HG; Gilbert M; Davidson JE; Winter C; Barratt MJ; Win B; Painter JL; Menone C; Sayegh J; Dasgupta N
    JMIR Public Health Surveill; 2017 Feb; 3(1):e6. PubMed ID: 28148472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bupropion: a review of its use in the management of smoking cessation.
    Holm KJ; Spencer CM
    Drugs; 2000 Apr; 59(4):1007-24. PubMed ID: 10804045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.